help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Endocrinology, doi:10.1210/en.2004-0518
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
145/11/4967    most recent
Author Manuscript (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Adams, S. H.
Right arrow Articles by Paterniti, J. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Adams, S. H.
Right arrow Articles by Paterniti, J. R., Jr.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*UniGene
*Compound via MeSH
*Substance via MeSH
Endocrinology Vol. 145, No. 11 4967-4975
Copyright © 2004 by The Endocrine Society

Effects of Peptide YY[3–36] on Short-Term Food Intake in Mice Are Not Affected by Prevailing Plasma Ghrelin Levels

Sean H. Adams, Wesley B. Won, Susan E. Schonhoff, Andrew B. Leiter and James R. Paterniti, Jr.

Pharmacology Department, Amylin Pharmaceuticals, Inc. (S.H.A., W.B.W., J.R.P.), San Diego, California 92121; and Division of Gastroenterology, Tufts-New England Medical Center (S.E.S., A.B.L.), Boston, Massachusetts 02111

Address all correspondence and requests for reprints to: Dr. Sean H. Adams, Pharmacology Department, Amylin Pharmaceuticals, Inc., 9360 Town Centre Drive, San Diego, California 92121. E-mail: sadams{at}amylin.com.

The gut-derived hormones peptide YY[3–36] (PYY[3–36]) and ghrelin are believed to influence similar hypothalamic circuits, albeit with opposing actions on energy balance. Thus, we carried out a series of studies to evaluate the interaction of these hormones on short-term food intake responses in mice. Intraperitoneal PYY[3–36] injection reduced short-term food intake by up to 50% in overnight-fasted mice and in postabsorptive animals during the early and late light cycle. This effect was not sensitive to the prevailing endogenous plasma acyl-ghrelin concentrations, which ranged from high physiological (overnight-fasted, 1252 ± 108 pg/ml) to low levels (late light cycle, 402 ± 33 pg/ml). PYY[3–36] administration did not reduce plasma total or acyl-ghrelin concentration in conjunction with its anorexigenic actions. Ghrelin increased short-term food intake by up to 1.8-fold in mice treated ip in the early light cycle, but was ineffective in animals treated after an overnight fast or during the late light cycle. Ghrelin did not increase food intake or GH secretion unless plasma levels were increased above high physiological fasting values. The anorexigenic effect of PYY[3–36] over a range of doses was not compromised by coinjection of ghrelin, and PYY[3–36] reduced food intake in agouti mice, which lack fully functional melanocortin signaling. These results in mice support a model in which 1) PYY[3–36] diminishes short-term food intake at least in part through mechanisms distinct from the neuropeptide Y/proopiomelanocortin neural circuits engaged by ghrelin; and 2) a reduction in circulating ghrelin is not requisite for the anorexigenic effects of PYY[3–36].




This article has been cited by other articles:


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
S. Unniappan and T. J. Kieffer
Leptin extends the anorectic effects of chronic PYY(3-36) administration in ad libitum-fed rats
Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2008; 295(1): R51 - R58.
[Abstract] [Full Text] [PDF]


Home page
Ann Clin BiochemHome page
V. E F Crowley
Overview of human obesity and central mechanisms regulating energy homeostasis
Ann Clin Biochem, May 1, 2008; 45(3): 245 - 255.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
E. T. Parlevliet, A. C. Heijboer, J. P. Schroder-van der Elst, L. M. Havekes, J. A. Romijn, H. Pijl, and E. P. M. Corssmit
Oxyntomodulin ameliorates glucose intolerance in mice fed a high-fat diet
Am J Physiol Endocrinol Metab, January 1, 2008; 294(1): E142 - E147.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
T. J Little, M. Horowitz, and C. Feinle-Bisset
Modulation by high-fat diets of gastrointestinal function and hormones associated with the regulation of energy intake: implications for the pathophysiology of obesity
Am. J. Clinical Nutrition, September 1, 2007; 86(3): 531 - 541.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
K. G. Murphy, W. S. Dhillo, and S. R. Bloom
Gut Peptides in the Regulation of Food Intake and Energy Homeostasis
Endocr. Rev., December 1, 2006; 27(7): 719 - 727.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
P. K. Chelikani, A. C. Haver, and R. D. Reidelberger
Ghrelin Attenuates the Inhibitory Effects of Glucagon-Like Peptide-1 and Peptide YY(3-36) on Food Intake and Gastric Emptying in Rats
Diabetes, November 1, 2006; 55(11): 3038 - 3046.
[Abstract] [Full Text] [PDF]


Home page
J EndocrinolHome page
T. Ito, H. ThidarMyint, T. Murata, H. Inoue, R. M. Neyra, and H. Kuwayama
Effects of peripheral administration of PYY3-36 on feed intake and plasma acyl-ghrelin levels in pigs.
J. Endocrinol., October 1, 2006; 191(1): 113 - 119.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
F. Bacha and S. A. Arslanian
Ghrelin and Peptide YY in Youth: Are There Race-Related Differences?
J. Clin. Endocrinol. Metab., August 1, 2006; 91(8): 3117 - 3122.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
A. A. Young
Obesity: A Peptide YY-Deficient, But Not Peptide YY- Resistant, State
Endocrinology, January 1, 2006; 147(1): 1 - 2.
[Full Text] [PDF]


Home page
J. Nutr.Home page
S. H. Adams, C. Lei, C. M. Jodka, S. E. Nikoulina, J. A. Hoyt, B. Gedulin, C. M. Mack, and E. S. Kendall
PYY[3-36] Administration Decreases the Respiratory Quotient and Reduces Adiposity in Diet-Induced Obese Mice
J. Nutr., January 1, 2006; 136(1): 195 - 201.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
T. Siahanidou, H. Mandyla, M. Vounatsou, D. Anagnostakis, I. Papassotiriou, and G. P. Chrousos
Circulating Peptide YY Concentrations Are Higher in Preterm than Full-Term Infants and Correlate Negatively with Body Weight and Positively with Serum Ghrelin Concentrations
Clin. Chem., November 1, 2005; 51(11): 2131 - 2137.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
T. Talsania, Y. Anini, S. Siu, D. J. Drucker, and P. L. Brubaker
Peripheral Exendin-4 and Peptide YY3-36 Synergistically Reduce Food Intake through Different Mechanisms in Mice
Endocrinology, September 1, 2005; 146(9): 3748 - 3756.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
S. Schonhoff, L. Baggio, C. Ratineau, S. K. Ray, J. Lindner, M. A. Magnuson, D. J. Drucker, and A. B. Leiter
Energy Homeostasis and Gastrointestinal Endocrine Differentiation Do Not Require the Anorectic Hormone Peptide YY
Mol. Cell. Biol., May 15, 2005; 25(10): 4189 - 4199.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
P. K. Chelikani, A. C. Haver, and R. D. Reidelberger
Intravenous Infusion of Peptide YY(3-36) Potently Inhibits Food Intake in Rats
Endocrinology, February 1, 2005; 146(2): 879 - 888.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2004 by The Endocrine Society